South San Francisco and San Diego, CA — Explora BioLabs, a preclinical facility operator and service provider headquartered in San Diego, announces its expansion into South San Francisco. Explora has leased approximately 18,000 square feet of purpose-built pharmacology space in the landmark Genesis SSF tower, located at One Tower Place along Highway 101, bordering the South San Francisco (SSF) life sciences cluster. Explora anticipates commencing its SSF operations in the second quarter of 2017.
Explora’s SSF facility will provide state-of-the-art workspace for clients’ pharmacology research operations; a conference room; cell culture rooms; all needed equipment and supplies; and regulatory and staffing support.
“Our flexible, full-service pharmacology accelerator model has proven very popular with biotech and pharma researchers in San Diego. We will soon be able to offer Bay Area companies the same quality, cost-savings, and convenience of performing their preclinical pharmacology research programs at a well-managed, professionally-staffed facility,” said Richard Lin, PhD, CEO and Founder, Explora BioLabs.
With the opening of its Genesis SSF facility, currently being developed by Phase 3 Real Estate Partners, Explora will operate over 60,000 square feet of turn-key, on-demand preclinical pharmacology space in California. Explora currently operates four AAALAC-accredited facilities in San Diego, with a fifth, also being developed by Phase 3 Real Estate Partners, opening in Q4 2016.
About Explora BioLabs
Explora BioLabs is an AAALAC-accredited preclinical contract research organization (CRO) that provides scientific services, on-demand pharmacology facilities, and OnSite facility operations to the biotech industry. Explora’s contract research services include the design and execution of preclinical studies in oncology, wound healing, metabolic diseases, pharmacokinetics, and toxicology. Explora’s turn-key pharmacology co-working labs serve clients who want to externalize their preclinical research facilities and take advantage of Explora’s proven scientific and operational expertise, while controlling their own research and reducing their lead time, upfront capital, and human resource investments. Explora’s OnSite services bring the benefits of Explora’s high quality operations into clients’ own research facilities. Additional information is available at www.explorabiolabs.com.
Richard Lin, PhD
CEO and Founder
Explora BioLabs, Inc.